A Study to Characterize the Pharmacokinetics of DA-8031 in Healthy Male Subjects

Summary

This is a dose block-randomized, double-blind, placebo-controlled, single/multiple dosing, dose-escalation study. The study is designed to describe the relationship between multiple doses and pharmacokinetic parameters of DA-8031 as well as safety profile.

Timeline

Start

2010-05

Primary completion

2011-10

Completion

2011-10

Drugs

Indications